Study of Flavocoxid (Limbrel) Versus Naproxen in Subjects With Moderate-Severe Osteoarthritis of the Knee
Completed · Not applicable · Has a placebo group
Conditions studied: Osteoarthritis
In brief
The purpose of the study is to compare the efficacy and safety of flavocoxid (Limbrel) with Naproxen and placebo in OA of the knee.
Key facts
- Study ID
- NCT00928837
- Run by
- Primus Pharmaceuticals
- People needed
- 350
- Starts
- 2006-03-01
- Expected to finish
- 2007-09-01
- Last updated by the study team
- 2017-12-13
Who can join
Age: 35 and older, up to 85. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Alan Kivitz MD — Duncansville, Pennsylvania, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.